BioMarin Pharmaceutical Inc. buy Oppenheimer Holdings Inc.
Start price
24.02.25
/
50%
€66.28
Target price
24.02.26
€93.59
Performance (%)
-20.31%
End price
25.02.26
€52.82
Summary
This prediction ended on 25.02.26 with a price of €52.82. The prediction for BioMarin Pharmaceutical Inc. disappointed with a performance of -20.31%. Oppenheimer_Holdings has a follow-up prediction for BioMarin Pharmaceutical Inc. where he still thinks BioMarin Pharmaceutical Inc. is a Buy. Oppenheimer_Holdings has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| BioMarin Pharmaceutical Inc. | -0.838% | -0.838% | -23.131% |
| iShares Core DAX® | 0,05 % | 1,31 % | 11,38 % |
| iShares Nasdaq 100 | 1,60 % | -0,90 % | 7,29 % |
| iShares Nikkei 225® | 3,06 % | 12,95 % | 33,77 % |
| iShares S&P 500 | 0,82 % | 0,70 % | 4,93 % |
Comments by Oppenheimer_Holdings for this prediction
In the thread BioMarin Pharmaceutical Inc. diskutieren
BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) was upgraded by analysts at Oppenheimer Holdings Inc. from a "market perform" rating to an "outperform" rating. They now have a $98.00 price target on the stock.
Ratings data for BMRN provided by MarketBeat
In the thread Trading BioMarin Pharmaceutical Inc.
Die von Oppenheimer_Holdings gewählte maximale Laufzeit wurde überschritten
Current prediction by Oppenheimer_Holdings for BioMarin Pharmaceutical Inc.
BioMarin Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€53.20
24.02.26
24.02.26
€80.62
24.02.27
24.02.27
-2.18%
25.02.26
25.02.26
